KRMD (KRMD) CEO receives 286,697 performance stock units tied to 2030 goals

Rhea-AI Filing Summary

KALBERMATTEN ADAM R reported acquisition or exercise transactions in this Form 4 filing.

KORU Medical Systems reported that President and CEO Adam R. Kalbermatten received a grant of 286,697 Performance Stock Units, each tied to an equal number of common shares. These awards were made under his amended and restated employment agreement as part of equity-based compensation.

According to the performance terms, 215,023 units may vest based on achieving a target level of the company's net sales growth on or prior to 12/31/2030, and 71,674 units may vest based on reaching a specified company market capitalization at 12/31/2030. All 286,697 units are reported as directly held following this grant.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KALBERMATTEN ADAM R

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Performance Stock Unit	286,697	$0.00	--

Holdings After Transaction: Performance Stock Unit — 286,697 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Performance Stock Units granted: 286,697 units Underlying common shares: 286,697 shares Net sales growth vesting tranche: 215,023 units +3 more

6 metrics

Performance Stock Units granted 286,697 units Grant to President and CEO Adam R. Kalbermatten

Underlying common shares 286,697 shares Each unit corresponds to one share of common stock

Net sales growth vesting tranche 215,023 units May vest based on company net sales growth by 12/31/2030

Market cap vesting tranche 71,674 units May vest based on company market capitalization at 12/31/2030

Total units held after grant 286,697 units Direct holdings of performance stock units following this transaction

Exercise price $0.00 per unit Grant/award acquisition with no exercise price

Key Terms

Performance Stock Unit, net sales growth, market capitalization, amended and restated employment agreement

4 terms

Performance Stock Unit financial

"Performance stock unit awards pursuant to reporting person's amended and restated employment agreement"

A performance stock unit is a type of reward companies give to employees, usually managers, that depends on how well the company performs over time. If the company hits specific goals, the employee earns shares of stock, like earning a prize for reaching certain levels in a game. It motivates employees to work hard because their rewards are tied to the company's success.

net sales growth financial

"215,023 may vest based on a target of the Company's net sales growth on or prior to 12/31/2030"

market capitalization financial

"71,674 may vest based on a target of the Company's market capitalization at 12/31/2030"

Market capitalization is the total market value of a company’s outstanding shares, calculated by multiplying the current share price by the number of shares issued. It gives a quick snapshot of a company’s size and how investors value it, influencing perceived risk, index membership, and roughly how much it might cost to buy the whole company — like using a sticker price to compare the relative size and price of different houses.

amended and restated employment agreement financial

"Performance stock unit awards pursuant to reporting person's amended and restated employment agreement"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:03 PM Accepted by SEC EDGAR 07/02/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KALBERMATTEN ADAM R

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NEW JERSEY 07430

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Unit	(1)	07/01/2026		A		286,697		(1)	(1)	Common Stock	286,697	$0	286,697	D

Explanation of Responses:

1. Performance stock unit awards pursuant to reporting person's amended and restated employment agreement, of which 215,023 may vest based on a target of the Company's net sales growth on or prior to 12/31/2030 and 71,674 may vest based on a target of the Company's market capitalization at 12/31/2030.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.

	/s/ Thomas Adams - Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did KORU Medical Systems (KRMD) report for its CEO?

KORU Medical Systems reported a grant of 286,697 Performance Stock Units to President and CEO Adam R. Kalbermatten. These equity awards are compensation-based and tied to future performance targets rather than an open-market stock purchase or sale.

How many Performance Stock Units did the KRMD CEO receive in this Form 4 filing?

Adam R. Kalbermatten received 286,697 Performance Stock Units, each linked to one share of common stock. All 286,697 units are shown as directly held following the grant, establishing a performance-based equity position for the CEO tied to long-term company results.

What performance goals affect vesting of the KRMD CEO’s new stock units?

The Performance Stock Units vest based on two long-term metrics: company net sales growth and market capitalization. 215,023 units may vest if a net sales growth target is met by 12/31/2030, and 71,674 units may vest if a market capitalization target is reached on 12/31/2030.

Is the KRMD CEO’s Form 4 transaction a stock purchase or sale?

The transaction is an award, not a market trade. The CEO acquired 286,697 Performance Stock Units at no exercise price as compensation. Vesting depends on future performance, so no open-market buying or selling occurred in this filing.

When do the KRMD CEO’s Performance Stock Units potentially vest?

The units are tied to performance through 12/31/2030. 215,023 units may vest based on net sales growth achieved on or before that date, while 71,674 units may vest depending on the company’s market capitalization measured on 12/31/2030.